193 related articles for article (PubMed ID: 3802104)
1. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor.
Kondo Y; Satoh M; Imura N; Akimoto M
Anticancer Res; 1992; 12(6B):2303-7. PubMed ID: 1295477
[TBL] [Abstract][Full Text] [Related]
3. Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum.
Kondo Y; Himeno S; Satoh M; Naganuma A; Nishimura T; Imura N
Cancer Chemother Pharmacol; 2004 Jan; 53(1):33-8. PubMed ID: 14530870
[TBL] [Abstract][Full Text] [Related]
4. Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
Imura N; Naganuma A; Satoh M; Koyama Y
Experientia Suppl; 1987; 52():655-60. PubMed ID: 2959559
[TBL] [Abstract][Full Text] [Related]
5. Protective role of metallothionein in renal toxicity of cisplatinum.
Satoh M; Aoki Y; Tohyama C
Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
[TBL] [Abstract][Full Text] [Related]
6. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
Satoh M; Kloth DM; Kadhim SA; Chin JL; Naganuma A; Imura N; Cherian MG
Cancer Res; 1993 Apr; 53(8):1829-32. PubMed ID: 8467502
[TBL] [Abstract][Full Text] [Related]
7. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
[TBL] [Abstract][Full Text] [Related]
8. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1988; 21(2):176-8. PubMed ID: 3349566
[TBL] [Abstract][Full Text] [Related]
10. [Role of metallothionein in cancer chemotherapy].
Naganuma A; Imura N
Gan To Kagaku Ryoho; 1994 Feb; 21(3):301-6. PubMed ID: 8109985
[TBL] [Abstract][Full Text] [Related]
11. Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor.
Kondo Y; Satoh M; Imura N; Akimoto M
Cancer Chemother Pharmacol; 1991; 29(1):19-23. PubMed ID: 1742844
[TBL] [Abstract][Full Text] [Related]
12. Effect of copper pretreatment on toxicity and antitumor activity of cis-diamminedichloroplatinum in mice.
Naganuma A; Satoh M; Imura N
Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):265-74. PubMed ID: 6542689
[TBL] [Abstract][Full Text] [Related]
13. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
Berry JP; Pauwells C; Tlouzeau S; Lespinats G
Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
[TBL] [Abstract][Full Text] [Related]
14. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
[TBL] [Abstract][Full Text] [Related]
15. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
[TBL] [Abstract][Full Text] [Related]
16. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
17. Toxicologic evaluation of cis-diamminedichloroplatinum II in B6D2F1 mice.
Harrison SD
Fundam Appl Toxicol; 1981; 1(5):382-5. PubMed ID: 6892237
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
20. [The effect of zinc glycyrrhizate on toxicity and anticancer activity of cisplatin in mice].
Xu ZL; Guo JH; Song ST; Li MJ; Wu DZ
Yao Xue Xue Bao; 1993; 28(8):567-71. PubMed ID: 8285063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
